Effect of Sildenafil on Pre-Eclampsia-Like Mouse Model Induced By L-Name

Reproduction in Domestic Animals

Volumn 50, Issue 4, 2015, Pages 611-616

  Motta, C ^a   Grosso, C ^a   Zanuzzi, C ^b,c   Molinero, D ^a   Picco, N ^a   Bellingeri, R ^a   Alustiza, F ^a   Barbeito, C ^b,c   Vivas, A ^a   Romanini, M C ^a  

^a DEPARTAMENTO DE QUÍMICA   (Argentina)

^b UNIVERSIDAD NACIONAL DE LA PLATA   (Argentina)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; MUS;

N(G) NITROARGININE METHYL ESTER; SILDENAFIL; VASODILATOR AGENT;

ANGIOGENESIS; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FEMALE; FETUS; MOUSE; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; VASCULARIZATION;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FETUS; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; NG-NITROARGININE METHYL ESTER; OXIDATIVE STRESS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; SILDENAFIL CITRATE; VASODILATOR AGENTS;

EID: 84936986379     PISSN: 09366768     EISSN: 14390531     Source Type: Journal    
DOI: 10.1111/rda.12536     Document Type: Article

References (32)

1. Baker PN, Davidge ST, Barankiewicz J, Roberts JM, 1996: Plasma of preeclamptic women stimulates and then inhibits endothelial prostacyclin. Hypertension 27, 56-61.
2. Buege J, Aust S, 1978: Microsomal lipid peroxidation. Methods Enzymol 52, 302-310.
3. Chance B, 1954: Special methods: catalase. In: Por Glick R (ed.), The Assay of Catalase and Peroxidases. Interscience, New York, pp. 408-424.
4. Dastjerdi MV, Hosseini S, Bayani L, 2012: Sildenafil citrate and uteroplace-ntal perfusion in fetal growth restriction. J Res Med Sci 17, 632-636.
5. Di Rienzo JA, Casanoves F, Balzarini MG, Gonzalez L, Tablada M, Robledo CW, 2012: Patente no. URL http://www.infostat.com.ar. Universidad Nacional de Córdoba, Argentina (accessed 29 December 2012).
6. Downing JW, Ramasubramanian R, Johnson RF, Minzter BH, Paschall RL, Sundell HW, Engelhardt B, Lewis R, 2004: Hypothesis: selective phosphodiesterase-5 inhibition improves outcome in preeclampsia. Med Hypotheses 63, 1057-1064.
7. Khalil RA, Granger JP, 2002: Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 283, R29-R45.
8. Laemmli UK, 1970: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
9. Ma RQ, Sun MN, Zang Z, 2010: Effects of preeclampsia-like symptoms at early gestational stage on feto-placental outcomes in a mouse model. Chin Med J 123, 707-712.
10. Maharaj CH, O'Toole D, Lynch T, Carney J, Jarman JD, Higgins B, Morrison JJ, Laffey JG, 2009: Effects and mechanisms of action of sildenafil citrate in human chorionic arteries. Reprod Biol Endocrinol 7, 34.
11. Molar M, Suto T, Toth T, Hertelendy F, 1994: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 170, 1458-1466.
12. Noris M, Perico N, Remuzzi G, 2005: Mechanisms of disease: preeclam-psia. Nat Clin Pract Nephrol 1, 98-114.
13. Osol G, Celia G, Gokina NI, 2005: Beneficial effects of viagra on fetal and vascular parameters in hypertensive pregnancy in the rat. FASEB J 19, A1597.
14. Program NH, 2000: Report of the national high blood pressure education. Am J Obstet Gynecol 183, S1-S22.
15. Pustovrh MC, Jawerbaum A, White V, Capobianco E, Higa R, Martínez N, López-Costa JJ, González E, 2007: The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Reproduction 134, 605-613.
16. Ramesar SV, Gathlram P, Moodley J, Mackraj I, 2012: Treatment of pre-eclampsia: implementing research findings. Gynecol Obstetric 2, 117.
17. Ramesar SV, Mackraj I, Gathiram P, Moodley J, 2010: Sildenafil citrate improves fetal outcomes in pregnant, L-NAME treated, Sprague-Dawley rats. Eur J Obstet Gynecol Reprod Biol 149, 22-26.
18. Roberts JM, Gammill HS, 2005: Preeclampsia recent insights. Hypertension 46, 1243-1249.
19. Salas SP, 1998: Role of nitric oxide in maternal hemodynamics and hormonal changes in pregnant rats. Biol Res 31, 243-250.
20. Santibanez JF, Letamendia A, Perez-Barriocanal F, 2007: Endoglin increases eNOS expression by modulating Smad2 protein levels and Smad2-dependent TGF-β signaling. J Cell Physiol 210, 456-468.
21. Sarifakioglu N, Gokrem S, Ates L, Akbuga UB, Aslan G, 2004: The influence of sildenafil on random skin flap survival in rats: an experimental study. Br J Plast Surg 57, 769-772.
22. Sasser JM, Baylis C, 2010: Effects of sildenafil on maternal hemodynamics and fetal growth in normal rat pregnancy. Am J Physiol Regul Integr Comp Physiol 298, 433-438.
23. Schäffer L, Vogel J, Breymann C, Gassmann M, Marti HH, 2006: Preserved placental oxygenation and development during severe systemic hypoxia. Am J Physiol Regul Integr Comp Physiol 290, R844-R851.
24. Sher G, Fisch JD, 2002: Effect of vaginal sildenafil on the outcome of in vitro fertilization (IVF) after multiple IVF failures attributed to poor endometrial development. Fertil Steril 78, 1073-1076.
25. Sher G, Fisch JD, 2000: Vaginal sildenafil (Viagra): a preliminary report of a novel method to improve uterine artery blood flow and endometrial development in patients undergoing IVF. Hum Reprod 15, 806-809.
26. Tammela T, Enholm B, Alitalo K, Paavonen K, 2005: The biology of vascular endothelial growth factors. Cardiovasc Res 65, 550-563.
27. von Dadelszen P, Dwinnell S, Magee LA, Carleton BC, Gruslin A, Lee B, Lim KI, Liston RM, Miller SP, Rurak D, Sherlock RL, Skoll MA, Wareing MM, Baker PN, 2011: Sildenafil citrate therapy for severe early-onset intrauterine growth restriction. BJOG 118, 624-628.
28. Wareing M, Myers JE, O'Hara M, Baker PN, 2005: Sildenafil citrate (viagra) enhances vasodilatation in fetal growth restriction. J Clin Endocrinol Metab 90, 2550-2555.
29. Wareing M, Myers JE, O'Hara M, Kenny LC, Taggart MJ, Skillern L, Machin I, Baker PN, 2006: Phosphodiesterase-5 inhibitors and omental and placental small artery function in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol 127, 41-49.
30. Wheeler-Jones C, Abu-Ghazaleh R, Cospedal R, Houliston RA, Martin J, Zachary I, 1997: Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase. FEBS Lett 420, 28-32.
31. Zoma WD, Baker RS, Clark KE, 2004: Effects of combined use of sildenafil citrate (Viagra) and 17b-estradiol on ovine coronary and uterine hemodynamics. Am J Obstet Gynecol 190, 1291-1297.
32. Zygmunt M, Herr F, Münstedt K, Lang U, Liang OD, 2003: Angiogenesis and vasculogenesis in pregnancy. Reprod Biol 110, S10-S18.